Key result
Dietary lipids and postprandial lipemia modify extracellular vesicles, serving as potential cardiometabolic mediators and biomarkers.
Why the study?
Extracellular vesicles have emerged as nanoparticles reflecting cellular lipid handling and contributing to interorgan signaling, but how dietary lipids and postprandial lipemia influence their lipid composition across the fasted-fed cycle required synthesis.
Postprandial extracellular vesicle lipidomes offer a novel framework for understanding cardiometabolic risk and the effects of dietary fat quality, complementing traditional fasting lipoprotein measures.
Answers are grounded in this paper and cite their sources.
Postprandial EV lipid signatures merit evaluation as cardiometabolic biomarkers; hypothesis-generating pending prospective validation.
Dietary fat intake acutely induces a dynamic postprandial state characterized by transient elevations in triacylglycerol-rich lipoproteins, circulating non-esterified fatty acids, and lipid mediators, superimposed on habitual diet and individual metabolic status. Within this context, extracellular vesicles (EVs) have emerged as lipid-bilayer nanoparticles whose lipid composition may reflect cellular lipid handling and contribute to interorgan signaling. This narrative review integrates mechanistic evidence, omics studies, and human feeding trials to examine how dietary lipids and postprandial lipemia may influence EV biogenesis and remodel EV lipid composition and molecular cargo across the fasted-fed cycle, while clearly distinguishing EV lipidomes from broader plasma and lipoprotein lipidomic changes. We highlight available evidence on the differential effects of fatty acid classes and dietary patterns on EV lipid signatures, pro-inflammatory and pro-thrombotic potential, and putative roles in endothelial dysfunction, adipose-liver-muscle crosstalk, immunometabolism, and insulin resistance. We also discuss methodological challenges in distinguishing EVs from lipoproteins in postprandial plasma, together with opportunities to use rigorously characterized postprandial EV signatures as integrative biomarkers of cardiometabolic risk and readouts of nutrition-based interventions. Overall, current evidence supports moving beyond a fasting, lipoprotein-centric perspective toward a postprandial framework in which EV lipidomes are investigated as complementary mediators and biomarkers of cardiometabolic disease.
No takes yet. Share an insight, caveat, or question.
Marquez‐Paradas et al. (2026) conducted a review in Cardiometabolic disease. Dietary fat intake was evaluated. Dietary lipids and postprandial lipemia influence extracellular vesicle biogenesis and lipid composition, serving as potential mediators and biomarkers of cardiometabolic disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: